SG182508A1 - Bioengineered tissue constructs and methods for producing and using thereof - Google Patents

Bioengineered tissue constructs and methods for producing and using thereof Download PDF

Info

Publication number
SG182508A1
SG182508A1 SG2012051769A SG2012051769A SG182508A1 SG 182508 A1 SG182508 A1 SG 182508A1 SG 2012051769 A SG2012051769 A SG 2012051769A SG 2012051769 A SG2012051769 A SG 2012051769A SG 182508 A1 SG182508 A1 SG 182508A1
Authority
SG
Singapore
Prior art keywords
bioengineered
cells
construct
bioengineered construct
extracellular matrix
Prior art date
Application number
SG2012051769A
Other languages
English (en)
Inventor
Vincent Ronfard
Dolores Baksh
Xianyan Wang
Matthew Quin-Men Wong
Lan Cao
Parid Sava
Thomas Bollenbach
Esin Yesilalan
Original Assignee
Organogenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organogenesis Inc filed Critical Organogenesis Inc
Publication of SG182508A1 publication Critical patent/SG182508A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/148—Transforming growth factor alpha [TGF-a]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG2012051769A 2010-01-14 2011-01-14 Bioengineered tissue constructs and methods for producing and using thereof SG182508A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29507310P 2010-01-14 2010-01-14
US33793810P 2010-02-12 2010-02-12
US34772510P 2010-05-24 2010-05-24
PCT/US2011/021362 WO2011088365A1 (en) 2010-01-14 2011-01-14 Bioengineered tissue constructs and methods for producing and using thereof

Publications (1)

Publication Number Publication Date
SG182508A1 true SG182508A1 (en) 2012-08-30

Family

ID=43881131

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2012051769A SG182508A1 (en) 2010-01-14 2011-01-14 Bioengineered tissue constructs and methods for producing and using thereof

Country Status (12)

Country Link
US (1) US20110293667A1 (https=)
EP (1) EP2524034A1 (https=)
JP (3) JP2013517292A (https=)
CN (2) CN107802890A (https=)
AU (1) AU2011205674A1 (https=)
BR (1) BR112012017463A2 (https=)
CA (1) CA2787050A1 (https=)
IL (1) IL220903A0 (https=)
MX (1) MX354068B (https=)
RU (1) RU2645473C2 (https=)
SG (1) SG182508A1 (https=)
WO (1) WO2011088365A1 (https=)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986377B2 (en) 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
US20120143228A1 (en) 2010-08-30 2012-06-07 Agency For Science Technology And Research Adhesive structure with stiff protrusions on adhesive surface
US9492952B2 (en) 2010-08-30 2016-11-15 Endo-Surgery, Inc. Super-hydrophilic structures
EP3851131A1 (en) * 2011-05-31 2021-07-21 LifeCell Corporation Adipose tissue matrices
US20130066370A1 (en) * 2011-09-06 2013-03-14 The Stem Cell Suture Company, LLC Surgical sutures and methods of making and using same
WO2013070899A1 (en) 2011-11-08 2013-05-16 Auxocell Laboratories, Inc. Systems and methods for processing cells
JP6153945B2 (ja) 2011-12-29 2017-06-28 エシコン・インコーポレイテッドＥｔｈｉｃｏｎ， Ｉｎｃｏｒｐｏｒａｔｅｄ 表面上に組織貫入突起を有する接着構造体
ES2812281T3 (es) 2012-01-13 2021-03-16 Lifecell Corp Métodos para fabricar prótesis mamarias
CN102599991A (zh) * 2012-03-20 2012-07-25 中山大学中山眼科中心 美容性角膜镜片的应用
US8969648B2 (en) 2012-04-06 2015-03-03 Ethicon, Inc. Blood clotting substrate and medical device
US8926881B2 (en) 2012-04-06 2015-01-06 DePuy Synthes Products, LLC Super-hydrophobic hierarchical structures, method of forming them and medical devices incorporating them
CA2876658C (en) 2012-06-21 2020-05-05 Lifecell Corporation Implantable prosthesis having acellular tissue attachments
US9533072B2 (en) * 2012-10-08 2017-01-03 Cormatrix Cardiovascular, Inc. Reinforced vascular prostheses
KR20180074818A (ko) 2013-02-08 2018-07-03 아셀, 인크. 세포외 기질 재료로부터의 생리활성 겔의 제조 방법
SG11201506312TA (en) 2013-02-12 2015-09-29 Replicel Life Sciences Inc Compositions and methods for treating and repairing tendons
WO2014125505A1 (en) * 2013-02-14 2014-08-21 Council Of Scientific & Industrial Research Silk based porous scaffold and a process for the preparation thereof
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
WO2015022670A1 (en) * 2013-08-14 2015-02-19 Stempeutics Research Pvt. Ltd. Management of osteoarthritis using pooled allogeneic mesenchymal stem cells
WO2015046216A1 (ja) * 2013-09-25 2015-04-02 富士フイルム株式会社 生体親和性高分子多孔質体の製造方法、生体親和性高分子多孔質体、生体親和性高分子ブロック並びに細胞構造体
US10959839B2 (en) * 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
GB201317889D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product and use
CL2013003066A1 (es) * 2013-10-22 2014-07-25 Univ Chile Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion
RU2559921C2 (ru) * 2013-11-01 2015-08-20 Игорь Иванович Агапов Способ восстановления целостности тонкой кишки
CN104726398A (zh) * 2013-12-20 2015-06-24 江阴司特易生物技术有限公司 固定化的全人源ecm包被基质的制备方法
WO2015123477A1 (en) 2014-02-12 2015-08-20 Replicel Life Sciences Inc. Compositions and methods for treating bone, joints and cartilage
PL3142586T3 (pl) 2014-05-14 2021-05-31 President And Fellows Of Harvard College Urządzenie cewnika do przesyłania i odbijania światła
US9993748B2 (en) 2014-08-11 2018-06-12 Auxocell Laboratories, Inc. Centrifuge clip and method
USD748462S1 (en) 2014-08-11 2016-02-02 Auxocell Laboratories, Inc. Centrifuge clip
EP3269402B1 (en) * 2015-03-12 2025-10-22 Adeka Corporation Anti-adhesion material and substitute biomembrane using decellularized tissue
CN104800891B (zh) * 2015-05-20 2017-03-29 苏州大学附属第一医院 一种增强体外培养间充质干细胞生物抗氧化功能的细胞外基质生物材料、制备方法及其应用
CN105769381B (zh) * 2015-05-26 2018-04-17 南通大学 一种用于组织损伤修复的生物补片
CN104958319A (zh) * 2015-06-01 2015-10-07 成都清科生物科技有限公司 具有卵巢早衰及围绝经期综合征治疗作用的间充质干细胞及其细胞因子制剂及其制备方法
WO2017003877A1 (en) * 2015-06-30 2017-01-05 Lattice Biologics Inc. Modified extracellular matrix for enhanced stem cell homing and engraftment
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
EP3337427A1 (en) 2015-08-21 2018-06-27 Lifecell Corporation Breast treatment device
CA3000401C (en) 2015-09-29 2022-09-27 Anicell Biotech, Llc Articles of manufacture containing decellularized and reconstituted fetal tissue and methods of making the same
CN105535946A (zh) * 2015-12-14 2016-05-04 北京大学第一医院 转谷氨酰胺酶在加强角膜力学性质中的应用及生物制剂
WO2017172638A1 (en) * 2016-03-29 2017-10-05 Smsbiotech, Inc. Compositions and methods for using small mobile stem cells
US20170281686A1 (en) * 2016-03-30 2017-10-05 Stembiosys, Inc. Bone marrow stromal cell derived extracellular matrix protein extract and uses thereof
RU2749991C2 (ru) 2016-08-31 2021-06-21 Лайфселл Корпорейшн Устройство для коррекции молочной железы
AU2017344747B2 (en) * 2016-10-20 2022-03-03 Australian Foundation for Diabetes Research Cell associated scaffolds for delivery of agents
CN106581760A (zh) * 2016-11-08 2017-04-26 华南生物医药研究院 增强细胞活性的特殊处理方法
CN106563161A (zh) * 2016-11-08 2017-04-19 华南生物医药研究院 可用于美容的新型药物组合剂
CN106619721A (zh) * 2016-11-08 2017-05-10 中国人民解放军军事医学科学院野战输血研究所 一种增强细胞活性的新方法
WO2018123814A1 (ja) * 2016-12-28 2018-07-05 株式会社高研 高強度コラーゲンスポンジ
US10368991B2 (en) * 2017-02-06 2019-08-06 C. R. Bard, Inc. Device and associated percutaneous minimally invasive method for creating a venous valve
KR20180099482A (ko) * 2017-02-27 2018-09-05 고려대학교 산학협력단 하이드로겔 중합체를 이용한 탈세포화 조직의 제조방법 및 이로부터 제조된 탈세포화 조직
CN111032090A (zh) * 2017-06-12 2020-04-17 北卡罗来纳大学教堂山分校 用于细胞植入的补片植入物组合物
CN107550935A (zh) * 2017-09-11 2018-01-09 上海亚睿生物科技有限公司 一种治疗关节疾病的生物凝胶剂及其应用
CL2017002357A1 (es) * 2017-09-16 2018-04-20 Cells For Cells S A Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos
KR102118522B1 (ko) 2017-10-25 2020-06-03 (주)셀라토즈테라퓨틱스 신규한 근골격계 줄기세포
US12258580B2 (en) 2017-11-01 2025-03-25 Juno Therapeutics, Inc. Process for generating therapeutic compositions of engineered cells
MX2020005907A (es) 2017-12-08 2020-10-19 Juno Therapeutics Inc Formulacion de medio libre de suero para cultivar celulas y metodos de uso de la misma.
CN119193493A (zh) 2017-12-08 2024-12-27 朱诺治疗学股份有限公司 生产工程化t细胞组合物的过程
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
CN108144128B (zh) * 2018-02-07 2021-11-05 陕西佰傲再生医学有限公司 一种多次交联乳房补片及其制备方法
CN108543116B (zh) * 2018-05-02 2021-04-27 深圳市华异生物科技有限责任公司 海藻酸钠与明胶复合水凝胶3d胰岛支架及其制备方法
US12516099B2 (en) 2018-08-09 2026-01-06 Juno Therapeutics, Inc. Processes for generating engineered cells and compositions thereof
KR20210072033A (ko) 2018-10-03 2021-06-16 스템바이오시스, 인크. 양수 세포-유래된 세포외 매트릭스 및 그의 용도
CN109793927A (zh) * 2019-01-24 2019-05-24 中国人民解放军军事科学院军事医学研究院 基于细胞外衍生基质修饰的丝素蛋白多孔支架的制备方法
EP3927814A1 (en) 2019-02-21 2021-12-29 Stembiosys, Inc. Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ecm, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds
CN110075357A (zh) * 2019-04-02 2019-08-02 浙江大学 一种脂肪干细胞与纳米丝素复合的骨修复材料的制备方法
WO2020207426A1 (zh) * 2019-04-10 2020-10-15 上海交通大学医学院附属上海儿童医学中心 一种体内植入性微孔囊袋及其使用方法和应用
US11298220B2 (en) 2019-05-03 2022-04-12 Lifecell Corporation Breast treatment device
CN110106148B (zh) * 2019-05-16 2020-10-13 中国人民解放军军事科学院军事医学研究院 一种组织工程化神经组织及其构建方法
CN110409059A (zh) * 2019-07-30 2019-11-05 北京化工大学常州先进材料研究院 甲基丙烯酸二甲氨基乙酯增强的丙烯酰化pgs纳米纤维膜的制备方法
CN112342187A (zh) * 2019-08-06 2021-02-09 中晶生物技术股份有限公司 一种软骨细胞培养基及其制备方法
CN110904044B (zh) * 2019-12-17 2022-07-19 陕西师范大学 一种肿瘤干细胞的三维培养方法
CN111407353A (zh) * 2020-02-26 2020-07-14 邹洪 一种新型蚕丝蛋白材料制作的结扎钉夹
US11725112B2 (en) * 2020-02-28 2023-08-15 Lawrence Livermore National Security, Llc Three-dimensional printed porous silicone matrix using leachable porogen
RU2749801C1 (ru) * 2020-03-06 2021-06-17 Галина Мироновна Могильная Способ восстановления утраченного объема дермы в эксперименте на крысах
US20210393852A1 (en) * 2020-06-19 2021-12-23 Mimedx Group, Inc. Meshed umbilical cord tissue grafts
CN111690604A (zh) * 2020-06-24 2020-09-22 杭州原生生物科技有限公司 一种msc体外扩增方法
KR102527152B1 (ko) * 2021-02-15 2023-04-28 울산과학기술원 강유전성 생분해 고분자층을 포함하는 전자 피부
CN113456893B (zh) * 2021-07-26 2022-04-26 温州医科大学附属眼视光医院 一种包被纤维蛋白原的蓝染羊膜基底膜的制备方法
IL314014A (en) * 2022-01-04 2024-08-01 Ronawk Inc Non-cellular substrates and methods for their preparation
CN115105637B (zh) * 2022-07-28 2023-11-10 上海交通大学医学院附属第九人民医院 结膜下成纤维细胞脱细胞基质在结膜重建方面的应用
WO2024092220A2 (en) * 2022-10-28 2024-05-02 University Of Connecticut Prosthetic device for tissue regeneration
CN117582557B (zh) * 2024-01-19 2024-03-19 四川恒普科技有限公司 脱矿骨纤维及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94611A (en) 1989-06-05 1994-12-29 Organogenesis Inc Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use
US5460962A (en) 1994-01-04 1995-10-24 Organogenesis Inc. Peracetic acid sterilization of collagen or collagenous tissue
WO1995031473A1 (en) 1994-05-11 1995-11-23 Organogenesis Inc. Collagen from cell cultures
AU4330597A (en) * 1996-08-30 1998-03-19 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
US5993844A (en) * 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US6291240B1 (en) * 1998-01-29 2001-09-18 Advanced Tissue Sciences, Inc. Cells or tissues with increased protein factors and methods of making and using same
EP2295540A1 (en) * 1998-11-19 2011-03-16 Organogenesis, Inc. Bioengineered tissue constructs and methods for producing and using them
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
WO2001011011A2 (en) * 1999-08-05 2001-02-15 Mcl Llc Multipotent adult stem cells and methods for isolation
JP2004535245A (ja) * 2001-07-16 2004-11-25 デピュイ・プロダクツ・インコーポレイテッド 多孔質細胞外基質支持骨格材料および方法
WO2003038075A1 (en) * 2001-10-30 2003-05-08 Renomedix Institute Inc. Method of inducing differentiation of mesodermal stem cells, es cells or immortalized cells into nervous system cells
EP1451299A4 (en) * 2001-12-11 2008-03-05 Cytograft Tissue Engineering I CELL AGENTS MADE BY TISSUE ENGINEERING, METHOD FOR THE PRODUCTION AND USE THEREOF
WO2004072273A1 (en) * 2003-02-11 2004-08-26 Davies John E Progenitor cells from wharton's jelly of human umbilical cord
AU2004261899A1 (en) * 2003-08-01 2005-02-10 Norimasa Nakamura Scaffold-free self-organized 3D synthetic tissue
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
AU2005302516A1 (en) * 2004-10-29 2006-05-11 Centocor, Inc. Chemically defined media compositions
WO2006099332A2 (en) * 2005-03-11 2006-09-21 Wake Forest University Health Sciences Production of tissue engineered digits and limbs
EP1863545B1 (en) * 2005-03-19 2015-11-18 Cook Biotech, Inc. Prosthetic implants including ECM composite material
JP4745750B2 (ja) * 2005-08-01 2011-08-10 株式会社ツーセル 動物幹細胞培養用無血清培地
MX369594B (es) * 2005-08-26 2019-11-13 Univ Minnesota Descelularizacion y recelularizacion de organos y tejidos.
DE602005017812D1 (de) * 2005-08-26 2009-12-31 Seoul Nat Univ Ind Foundation Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit
EP1998787A4 (en) * 2006-03-03 2010-04-21 Organogenesis Inc RECOVERY AND REPAIR OF ORAL TISSUE
CN101412985B (zh) * 2007-10-15 2012-06-13 华东理工大学 用于骨髓间充质干细胞体外培养和扩增的无血清培养基
CN100563728C (zh) * 2007-10-19 2009-12-02 中国人民解放军第四军医大学 含有外周血干细胞的组织工程皮肤及其制备方法
US20110293666A1 (en) * 2007-11-28 2011-12-01 Xianyan Wang Bioengineered Tissue Constructs and Methods for Production and Use
JP5795166B2 (ja) * 2007-11-28 2015-10-14 オルガノジェネシス インク． 生命工学による組織コンストラクト並びに生産及び使用のための方法
RU86455U1 (ru) * 2008-04-22 2009-09-10 ФГУ "Московский научно-исследовательский онкологический институт им. П.А. Герцена Федерального агентства по высокотехнологичной медицинской помощи" РФ Биоинженерная конструкция
WO2013090911A1 (en) * 2011-12-16 2013-06-20 Wisconsin Alumni Research Foundation Method for supporting human pluri potent stem cell cultures comprising culturing the cells in a medium comprising thermostable fgf - 1 proteins

Also Published As

Publication number Publication date
CA2787050A1 (en) 2011-07-21
US20110293667A1 (en) 2011-12-01
IL220903A0 (en) 2012-09-24
MX2012008215A (es) 2012-10-15
RU2645473C2 (ru) 2018-02-21
EP2524034A1 (en) 2012-11-21
CN107802890A (zh) 2018-03-16
MX354068B (es) 2018-02-09
CN102892880A (zh) 2013-01-23
AU2011205674A1 (en) 2012-08-09
JP2018117643A (ja) 2018-08-02
BR112012017463A2 (pt) 2015-09-15
JP2016182126A (ja) 2016-10-20
RU2012132705A (ru) 2014-02-20
JP2013517292A (ja) 2013-05-16
WO2011088365A1 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
US20110293667A1 (en) Bioengineered Tissue Constructs and Methods for Producing and Using Thereof
US20110293666A1 (en) Bioengineered Tissue Constructs and Methods for Production and Use
JP5795166B2 (ja) 生命工学による組織コンストラクト並びに生産及び使用のための方法
US20200276360A1 (en) Compositions and methods for cardiac therapy
Sharath et al. Human adipose tissue derivatives as a potent native biomaterial for tissue regenerative therapies
EP2513299A1 (en) Decellularized adipose tissue
WO2017136786A1 (en) Rigionally specific tissua-derived extracellular metrix
US10149924B1 (en) Ready to use biodegradable and biocompatible artificial skin substitute and a method of preparation thereof
Inci et al. Decellularized inner body membranes for tissue engineering: a review
JP5454980B2 (ja) 間葉系細胞増殖促進剤およびそれを含有する骨格系生体材料
Freytes et al. Biomaterial scaffolds for cardiac regeneration and repair derived from native heart matrix
Cheng Biomaterials for tendon/ligament and skin regeneration
Rassomakhina et al. Tissue Engineering and Cell Technologies in the Treatment of Urethral Strictures
Niu et al. Making a Hydrophilic Interfacial Scaffold with Hierarchical Nanofibre Architecture to Enhance the Phenotypic Expression of Epithelial and Smooth Muscle Cells for Urethral Reconstruction
Suesca et al. Collagen Substrates for Soft Tissue Engineering
Chiu Angiogenesis in Patches and Injectable Biomaterials for Cardiac Repair